1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and living with overweight or obesity ID6441

In development [GID-TA11544] Expected publication date: TBC

  • Project information
  • Project documents

26956-Semaglutide-for-Obesity-with-Cardiovascular-Disease-V1.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)